Atopic Dermatitis - The Dermatology Digest

TDD News Brief: Nevisense Can Detect Skin Barrier Dysfunction in AD

September 26, 2025

AD Pipeline Watch: Bambusa’s BBT001 Advances to Patient Dosing

September 25, 2025

Tralokinumab (Adbry, LEO Pharma) in AD: Reviewing New Data From the ECZTRA 3 and ECZTEND Trials With Dr. Andy Blauvelt

September 24, 2025

From the Podium to Your Practice: Dr. Christopher Bunick Discusses New Real-world Safety Data on Upadacitinib (Rinvoq, AbbVie) in AD

September 19, 2025

Breaking News: U.S. FDA Approves Ruxolitinib Cream 1.5% (Opzelura, Incyte) for Kids Age 2 and up With AD

September 18, 2025

AD Pipeline Watch: Rezpegaldesleukin Hits Primary and Key Secondary Endpoints in REZOLVE-AD Phase 2b Study

September 18, 2025

Advertisement

Advertisement

Latest Issue

Latest Supplements

Upcoming Conferences

Advertisement

Advertisement

Digital Edition Archive